A recent study showed these medicines caused lower IQ scores in children when mothers consumed them during pregnancy. Valproate’s pregnancy category will be changed from D, indicating potential benefit despite risks, to X, indicating risk outweighs any possible benefit, according to the report.
Valproate is approved to treat epilepsy, manic episodes associated with bipolar disorder and migraine headache prevention. Pregnant women should completely avoid it for migraines and should only use it for epilepsy or bipolar disorder if other treatments have failed.
More Articles on Anesthesia:
FDA Approves Sedasys Computer-Assisted System for GI Propofol Sedation
Masimo Rainbow Respiratory Monitor Cleared by FDA for Pediatric Use
Anesthesiologists Urge CMS, ONC to Continue Hardship Exemption Through MU Stage 3
